United States abuse of dominancepatents

FTC v Qualcomm Inc

969 F.3d 974 (9th Cir. 2020)

JurisdictionUnited States

CourtUS Court of Appeals for the Ninth Circuit

Year2020

StatusBinding authority

Summary

Ninth Circuit reversed antitrust finding against Qualcomm, holding SEP licensing at chipmaker level was not anticompetitive where rivals could still compete.

Key Principle

The Ninth Circuit reversed the district court's antitrust finding against Qualcomm, holding that licensing practices for standard-essential patents at the chipmaker level were not anticompetitive where rival chipmakers could still compete.

Area of Law

competition

Related Cases

ACCC v Pacific National Pty Ltd [2020] FCAFC 77

Full Federal Court considered the test for substantially lessening competition under s.50 CCA in the context of a rail freight acquisition.

ACCC v Yazaki Corporation (2018) 262 CLR 1

HCA upheld record cartel penalties for wire harness market conduct, affirming that penalties must deter contravener and others, considering nature, extent, and duration of cartel.

ACCC v Pfizer Australia Pty Ltd [2018] FCAFC 78

Full Federal Court considered whether Pfizer's patent evergreening strategy in the pharmaceutical market constituted misuse of market power under s 46 of the Competition and Consumer Act.

Ask CommonBench about this case

Get a detailed analysis of FTC v Qualcomm Inc and how it applies to your situation.

Explain FTC v Qualcomm Inc